Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co's Dr Daniel Pascheles joins Molekule Consulting

He becomes the biopharma services provider’s CEO

Molekule Consulting Dr Daniel PaschelesMiami, US-based Molekule Consulting has appointed Dr Daniel Pascheles as its new chief executive officer.

Dr Daniel Pascheles joins from Merck & Co, where he served as vice president and head of global competitive intelligence for the last 12 years.

While at Merck, Dr Pascheles provided strategy development, target and candidate identification for the firm's licensing, business development and M&A activities, alongside leading the CI department.

Prior to this, Dr Pascheles worked at Aventis Pharmaceuticals - as well as its predecessor companies - for over 14 years, latterly as its vice president.

His previous roles include head of global competitive intelligence, global marketing director, general manager of Switzerland and European head of sales, marketing administration and strategic planning.

David Alderman, Molekule Consulting's founder and president, said: “Dr Pascheles is one of the most experienced, ethical and well-respected CI professionals in our industry; he is a global leader who brings expertise and exceptional vision to build our growing company.”

6th January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics